CHMP5 and acute lymphoblastic leukemia: Our findings that impaired T-ALL initiation and maintenance in CHMP5-depleted T-ALL cells was at least in part due to disruption of the p300/BRD4 activity suggest a pro-tumorigenic role for p300 in T-ALL pathogenesis.